The prevalence of atopic dermatitis has increased all over the world and mostly it has been affecting infants and children. This problem includes food allergies, fever, allergic asthma, atopic dermatitis, and anaphylaxis.
According to the report published by the National Center for Biotechnology Information, and atopic dermatitis has affected around 20% of infants and children and 3% of adults at a global level. There has been rising funding along with the government support for the research and development boosting the growth of the atopic dermatitis market. Atopic dermatitis global market report showcases that the market will grow at a CAGR of 8.2% during the forecast period of 2017-2023.
The type of eczema has various patterns that depend on the age of the patients. It can occur anywhere in the body and can be characterized by a low quantity of filaggrin protein that allows for the skin to become dry and reduces the immunity ability. The market for this type of eczema is growing majorly, attributing to the prevalence of atopic disorders and the various technological developments in the medical devices field.
Market segmentation
The global atopic dermatitis market has been presented with the growing rate of the global market at a faster rate. The report also presents a detailed analysis of dermatitis that can be segmented based on the types, applications, and end-users.
On the basis of the type, the global market can be split into:
Monoclonal antibodies
- Hormone
- Erythropoietin
- Calcitonin
- Interferon
- Others
And based on the applications, the global atopic dermatitis market can be classified into:
- Chronic diseases
- Cancer
- Blood disorders
- Infectious diseases
- others
To order this detailed 800+ page report, please visit this link Key InclusionsAn overview of the current market landscape of companies engaged in manufacturing prefilled syringes, providing information on year of establishment, company size, geographical location of the headquarters and manufacturing facilities, type of material used (glass and plastic), number of barrel chambers (single chamber and dual chamber), type of needle system (fixed needle system, luer lock and luer cone) and syringe volume.An overview of the current market landscape of companies that are developing drugs in combination with prefilled syringes, featuring information on year of establishment, company size, geographical location of the developers, target therapeutic area, phases of development, type of drug molecule, route of administration, approval year (for marketed products), dosage details (for marketed products) and other approved dosage forms (for marketed products).A detailed competitiveness analysis of the various prefilled syringes that we came across, taking into consideration the supplier power (based on the employee size of developer / manufacturer and their respective annual revenues) and key product specifications, such as number of chambers in the barrel, number of needle systems, volume of the barrel, technological advancement / user-friendliness and other distinguishing features.A list of marketed drugs / therapies and pipeline candidates that are likely to be developed in combination with prefilled syringes in the near future, shortlisted based on an in-depth analysis that takes into consideration various relevant parameters, such as route of administration, type of drug molecule, target indications, other available dosage forms (for approved drugs) and historical annual sales information (for approved drugs).An analysis presenting potential strategic partners (primarily drug developers) for prefilled syringe manufacturers (with regard to likely collaboration opportunities for combination product development) based on different parameters, such as pipeline strength, target therapeutic indication(s) and developer strength.An analysis of the various prefilled syringe combination product-related initiatives of big pharma players, based on parameters, such as current adoption (based on number of approved and under development prefilled syringe combination products) and likely future adoption (based on potential injectable product candidates in the pipeline that are likely to be delivered via prefilled syringes), target therapeutic area(s) and type of drug molecule.A review of the landscape of contract fill / finish services providers that offer services for prefilled syringes, featuring a list of active (large-sized) service providers and analysis based on a number of relevant parameters, such as year of establishment, company size, scale of operation (preclinical, clinical and commercial), type of drug molecule (biologics and small molecules), and geographical location of the service provider.A detailed discussion on various safety features (add-on and integrated devices) installed in recent versions of prefilled syringes and the companies involved in developing and manufacturing such solutions.An informative summary of various guidelines established and issued by major regulatory bodies for the approval of prefilled syringes, across different countries / geographical regions.Brief discussions of currently available specialty syringes, which include prefilled flush syringes, prefilled diluent syringe systems and prefilled contrast agent delivery systems.A case study on companies that are engaged in the manufacturing of autoinjectors, featuring brief profiles of key players in this domain; each profile includes an overview of the firm, and information on its respective product portfolio.Elaborate profiles of prominent prefilled syringe manufacturers engaged in this domain, featuring a brief overview of the company, its financial information (if available), information on product portfolio, recent developments and an informed future outlook.
The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:Target therapeutic areaAutoimmune disordersInfectious diseasesNeurological disordersBlood disordersOncological disordersPsychiatric disordersRespiratory disordersCardiovascular disordersMetabolic disordersOphthalmic diseasesOrthopedic disordersOthers Type of syringeSpecialty syringes Type of syringe barrel materialGlassPlastic Number of barrel chambersSingle chamberDual chamber Key geographical regionsNorth AmericaEuropeLatin AmericaAsia PacificMiddle East and Africa To request sample pages, please visit this link Key Questions AnsweredWho are the key players engaged in the manufacturing of prefilled syringes, across the globe?What are the prevalent trends within the prefilled syringes market?What are the current regulatory requirements for securing marketing authorizations for prefilled syringe combination products, across different countries?What technological advances have taken place in the prefilled syringes market?What are the key growth drivers within the prefilled syringes market?Who are the key contract service providers in this domain?How is the current and future market opportunity likely to be distributed across key market segments?
You may also be interested in the following titles:Global Autoinjectors Market (3rd Edition), 2020-2030Novel Vaccine Delivery Devices Market, 2019-2030Microneedles and Needle-Free Injection Systems / Jet Injectors (Devices based on Spring, Gas and Other Mechanisms) Market, 2019-2030Medical Device Labels Manufacturing Market, 2019 - 2030 Contact UsGaurav Chaudhary+1 (415) 800 [email protected]
